Discovery Platform
A Powerful Tech Stack for Validating Difficult Targets
Announcing our Collaboration with AstralBio in Obesity and Cardiometabolic Conditions
Discovering, engineering, and developing new antibodies with our machine learning platform
Partner with iBio
License our discovery platform or collaborate with us to advance our high-value pipeline assets
AI-Powered Precision Antibody Therapeutics
Epitope-Steering and Antibody Optimization for Accelerating Cancer Immunotherapies
Discovery Platform
From precision antibody identification and optimization to tailored bispecifics and a cutting-edge masking technology
Antibody Masking With ShieldTx™
An antibody masking technology for delivering on-epitope, on-tissue clinical candidates with enhanced safety and developability
Optimize Bispecifics With EngageTx™
a CD3-BASED T-CELL ENGAGER Platform
Therapeutic Pipeline
RAPIDLY ADVANCING HARD-TO-ENGINEER ANTIBODIES
Therapeutic Candidates
Learn how we are deploying our AI Drug Discovery Platform to develop a robust immuno-oncology pipeline
The Expertise Behind the AI
Meet the team driving iBio’s powerful tech stack for drug discovery
